2+1 Team Delegate Pass (Amsterdam)
Master the Evidence-to-Access Landscape in Amsterdam
As the pharmaceutical industry prepares for the 2026 expansion of the Joint Clinical Assessment (JCA), cross-functional alignment is no longer optional, it is a business necessity. The 2nd Annual European RWE & Market Access Summit provides the definitive, non-academic roadmap for navigating the “PICO Explosion” and leveraging Darwin EU 2.0 for regulatory success.
Why the “Team of 3” (2+1) Pass?
Strategic Market Access requires a unified approach between RWE, HEOR, and Pricing teams. Our 2+1 Delegate Entry is specifically designed to allow your organization to send a multi-disciplinary team to ensure that insights from evidence generation are seamlessly integrated into payer negotiation strategies.
Key Strategic Pillars for 2026
EU-HTA & JCA Readiness: Move beyond theory with practical sessions on PICO framework definitions, comparator selection, and first lessons from 2025 pilots.
Next-Generation RWE & AI: Explore federated data, privacy-preserving analytics, and AI-driven quality improvements to meet decision-grade evidence standards.
Pricing & Reimbursement Excellence: Gain predictive frameworks for outcomes-based agreements and value-based contracting across G-BA, NICE, HAS, and AIFA expectations.
Darwin EU 2.0 Integration: Understand the technical requirements for multi-state data interoperability and the EMA’s evolving role in regulatory decision-making.
To ensure this product ranks highly for high-intent search terms like “European Market Access Summit 2026” and “JCA PICO Strategy Pharma,” the content must be structured to answer the specific technical “pain points” of your audience.
Product Specifications & Benefits
| Feature | Details |
| Access Level | Full 2-day access for three (3) delegates |
| Core Theme | Evidence to Access: Integrating AI, RWD, and JCA Strategy |
| Networking | Elite access to Decision-makers & Senior Leaders and 30+ expert speakers |
| Location | Amsterdam – Europe’s hub for regulatory science |
| Dates | October 21-22, 2026 |
Who Should Utilize the Team Pass?
This pass is ideal for high-level technical and commercial teams from Pharma, Biotech, and Digital Health:
VPs & Directors of Market Access and HEOR
Global Leads for RWE and Evidence Strategy
Pricing & Reimbursement Decision Makers
Regulatory Strategy and Medical Affairs Teams
Original price was: € 4499.€ 1799Current price is: € 1799.
